Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
- PMID: 36157533
- PMCID: PMC9367226
- DOI: 10.3748/wjg.v28.i29.3793
Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
Abstract
Chronic Hepatitis B is a highly prevalent disease worldwide and is estimated to cause more than 800000 annual deaths from complications such as cirrhosis and hepatocellular carcinoma (HCC). Although universal hepatitis B vaccination programs may have reduced the incidence and prevalence of chronic hepatitis B and related HCC, the disease still imposes a significant healthcare burden in many endemic regions such as Africa and the Asia-Pacific region. This is especially concerning given the global underdiagnosis of hepatitis B and the limited availability of vaccination, screening, and treatment in low-resource regions. Demographics including male gender, older age, ethnicity, and geographic location as well as low socioeconomic status are more heavily impacted by chronic hepatitis B and related HCC. Methods to mitigate this impact include increasing screening in high-risk groups according to national guidelines, increasing awareness and health literacy in vulnerable populations, and developing more robust vaccination programs in under-served regions.
Keywords: Epidemiology; Healthcare disparity; Hepatitis B; Hepatitis B vaccine; Hepatocellular carcinoma; Socioeconomic status.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: There are no conflicts of interest to report.
Figures
References
-
- World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact: web annex 2: data methods. July 15, 2021. [Cited 2 January 2022]. Available from: https://www.who.int/publications/i/item/9789240027077 .
-
- Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol. 2009;19:231–234. - PubMed
-
- Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555. - PubMed
-
- Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336:1855–1859. - PubMed
-
- McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, Parkinson AJ. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology. 2011;54:801–807. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
